151 related articles for article (PubMed ID: 38192977)
1. Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR.
Troschel FM; Eich HT; Greve B
Transl Cancer Res; 2023 Dec; 12(12):3223-3226. PubMed ID: 38192977
[No Abstract] [Full Text] [Related]
2. HuR Reduces Radiation-Induced DNA Damage by Enhancing Expression of ARID1A.
Andrade D; Mehta M; Griffith J; Oh S; Corbin J; Babu A; De S; Chen A; Zhao YD; Husain S; Roy S; Xu L; Aube J; Janknecht R; Gorospe M; Herman T; Ramesh R; Munshi A
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31847141
[TBL] [Abstract][Full Text] [Related]
3. HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
Mehta M; Basalingappa K; Griffith JN; Andrade D; Babu A; Amreddy N; Muralidharan R; Gorospe M; Herman T; Ding WQ; Ramesh R; Munshi A
Oncotarget; 2016 Oct; 7(40):64820-64835. PubMed ID: 27588488
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
Badawi A; Hehlgans S; Pfeilschifter J; Rödel F; Eberhardt W
Cancer Lett; 2017 May; 393():103-112. PubMed ID: 28219770
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of caspases protects mice from radiation-induced oral mucositis and abolishes the cleavage of RNA-binding protein HuR.
Talwar S; House R; Sundaramurthy S; Balasubramanian S; Yu H; Palanisamy V
J Biol Chem; 2014 Feb; 289(6):3487-500. PubMed ID: 24362034
[TBL] [Abstract][Full Text] [Related]
7. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
Wu M; Tong CWS; Yan W; To KKW; Cho WCS
Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
[TBL] [Abstract][Full Text] [Related]
8. The kinesin light chain-2, a target of mRNA stabilizing protein HuR, inhibits p53 protein phosphorylation to promote radioresistance in NSCLC.
Qiao S; Jiang Y; Li N; Zhu X
Thorac Cancer; 2023 Jun; 14(16):1440-1450. PubMed ID: 37055376
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein HuR in human cancer: A friend or foe?
Wu X; Xu L
Adv Drug Deliv Rev; 2022 May; 184():114179. PubMed ID: 35248670
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal RNA binding motif of HuR is a multi-functional domain leading to HuR oligomerization and binding to U-rich RNA targets.
Scheiba RM; de Opakua AI; Díaz-Quintana A; Cruz-Gallardo I; Martínez-Cruz LA; Martínez-Chantar ML; Blanco FJ; Díaz-Moreno I
RNA Biol; 2014; 11(10):1250-61. PubMed ID: 25584704
[TBL] [Abstract][Full Text] [Related]
11. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into binding dynamics of tandem RNA recognition motifs (tRRMs) of human antigen R (HuR) with mRNA and the effect of point mutations in impaired HuR-mRNA recognition.
Agarwal A; Alagar S; Kant S; Bahadur RP
J Biomol Struct Dyn; 2023 Jul; 41(11):4830-4846. PubMed ID: 35538713
[TBL] [Abstract][Full Text] [Related]
13. Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma.
Janakiraman H; House RP; Talwar S; Courtney SM; Hazard ES; Hardiman G; Mehrotra S; Howe PH; Gangaraju V; Palanisamy V
Oncogene; 2017 Jun; 36(22):3137-3148. PubMed ID: 27941877
[TBL] [Abstract][Full Text] [Related]
14. Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer.
Guo X; Wu Y; Hartley RS
Mol Carcinog; 2010 Feb; 49(2):130-40. PubMed ID: 19777567
[TBL] [Abstract][Full Text] [Related]
15. Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.
Shi Q; Lee DY; Féliers D; Abboud HE; Bhat MA; Gorin Y
Mol Metab; 2020 Jun; 36():100968. PubMed ID: 32240965
[TBL] [Abstract][Full Text] [Related]
16. Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR.
Joseph BP; Weber V; Knüpfer L; Giorgetti A; Alfonso-Prieto M; Krauß S; Carloni P; Rossetti G
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685931
[TBL] [Abstract][Full Text] [Related]
17. HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models.
Assoni G; La Pietra V; Digilio R; Ciani C; Licata NV; Micaelli M; Facen E; Tomaszewska W; Cerofolini L; Pérez-Ràfols A; Varela Rey M; Fragai M; Woodhoo A; Marinelli L; Arosio D; Bonomo I; Provenzani A; Seneci P
Adv Drug Deliv Rev; 2022 Feb; 181():114088. PubMed ID: 34942276
[TBL] [Abstract][Full Text] [Related]
18. [Circular RNA circRSF1 binds to HuR to promote radiation-induced inflammatory phenotype in hepatic stellate cells].
Zhou P; Cheng B; Sun Y; Wu D; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):46-51. PubMed ID: 36856209
[TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1).
Wigington CP; Jung J; Rye EA; Belauret SL; Philpot AM; Feng Y; Santangelo PJ; Corbett AH
J Biol Chem; 2015 Feb; 290(6):3468-87. PubMed ID: 25519906
[TBL] [Abstract][Full Text] [Related]
20. The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding.
Wang H; Zeng F; Liu Q; Liu H; Liu Z; Niu L; Teng M; Li X
Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):373-80. PubMed ID: 23519412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
